Syncom Formulations P/B Ratio
Syncom Formulations P/B ratio. Syncom Formulations (SYNCOMF) P/B ratio is 5.71 (High), book value per share ₹44.15 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see SYNCOMF stock price BSE.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
SYNCOMF P/B Ratio — Valuation Insights & Book Value Analysis
Syncom Formulations price-to-book ratio interpretation, valuation status and historical context — current P/B 5.71 (High). Analyse SYNCOMF shareholding pattern to track promoter, FII and institutional holdings.
- Stock appears overvalued with PB of 5.71, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 1065.3% above historical average
- Trading at premium to sector average PB of 0.01
Syncom Formulations P/B Ratio Historical Trend
SYNCOMF annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View SYNCOMF yearly price range for the annual high/low range and current price position.
SYNCOMF Historical P/B Ratio — Book Value Per Share & Year-End Price
Syncom Formulations annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.52 | ₹44.15 | ₹23.14 | ₹415 | Low |
| 2025 | 0.39 | ₹36.38 | ₹14.26 | ₹342 | Low |
| 2024 | 0.65 | ₹30.64 | ₹20.00 | ₹288 | Low |
| 2023 | 0.55 | ₹27.23 | ₹15.04 | ₹256 | Low |
| 2022 | 0.34 | ₹25.81 | ₹8.88 | ₹222 | Low |
SYNCOMF vs Healthcare Peers — P/B Ratio Comparison
Syncom Formulations P/B 5.71 vs Healthcare average 0.01, median 0.61 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.19 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |